215 related articles for article (PubMed ID: 19734420)
1. Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.
Gallardo D; de la Cámara R; Nieto JB; Espigado I; Iriondo A; Jiménez-Velasco A; Vallejo C; Martín C; Caballero D; Brunet S; Serrano D; Solano C; Ribera JM; de la Rubia J; Carreras E
Haematologica; 2009 Sep; 94(9):1282-8. PubMed ID: 19734420
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
[TBL] [Abstract][Full Text] [Related]
3. Improved outcomes using G-CSF-mobilized blood and bone marrow grafts as the source of stem cells compared with G-PB after HLA-identical sibling transplantation in patients with acute leukemia.
Zhao XS; Chen Y; Zhao XY; Liu DH; Xu LP; Wang Y; Han W; Chen YH; Chen H; Zhang XH; Liu KY; Huang XJ
Clin Transplant; 2013; 27(6):844-51. PubMed ID: 23992032
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism.
Beelen DW; Ottinger HD; Elmaagacli A; Scheulen B; Basu O; Kremens B; Havers W; Grosse-Wilde H; Schaefer UW
Blood; 1997 Dec; 90(12):4725-35. PubMed ID: 9389688
[TBL] [Abstract][Full Text] [Related]
5. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
6. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
7. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
Bensinger WI; Martin PJ; Storer B; Clift R; Forman SJ; Negrin R; Kashyap A; Flowers ME; Lilleby K; Chauncey TR; Storb R; Appelbaum FR
N Engl J Med; 2001 Jan; 344(3):175-81. PubMed ID: 11172139
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
[TBL] [Abstract][Full Text] [Related]
10. Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donors.
Yamasaki S; Henzan H; Ohno Y; Yamanaka T; Iino T; Itou Y; Kuroiwa M; Maeda M; Kawano N; Kinukawa N; Miyamoto T; Nagafuji K; Shimoda K; Inaba S; Hayashi S; Taniguchi S; Shibuya T; Gondo H; Otsuka T; Harada M;
Bone Marrow Transplant; 2003 Sep; 32(5):505-10. PubMed ID: 12942097
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation.
Bensinger WI; Clift R; Martin P; Appelbaum FR; Demirer T; Gooley T; Lilleby K; Rowley S; Sanders J; Storb R; Buckner CD
Blood; 1996 Oct; 88(7):2794-800. PubMed ID: 8839878
[TBL] [Abstract][Full Text] [Related]
12. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia.
Ji SQ; Chen HR; Wang HX; Yan HM; Pan SP; Xun CQ
Biol Blood Marrow Transplant; 2002; 8(5):261-7. PubMed ID: 12064363
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
14. Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study.
Couban S; Aljurf M; Lachance S; Walker I; Toze C; Rubinger M; Lipton JH; Lee SJ; Szer J; Doocey R; Lewis ID; Huebsch L; Howson-Jan K; Lalancette M; Almohareb F; Chaudhri N; Ivison S; Broady R; Levings M; Fairclough D; Devins G; Szwajcer D; Foley R; Smith C; Panzarella T; Kerr H; Kariminia A; Schultz KR
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1410-1415. PubMed ID: 27154847
[TBL] [Abstract][Full Text] [Related]
15. Survival and graft-versus-host disease in patients receiving peripheral stem cell compared to bone marrow transplantation from HLA-matched related donor: retrospective analysis of 334 consecutive patients.
Campregher PV; Hamerschlak N; Colturato VA; Mauad MA; de Souza MP; Bouzas LF; Tavares Rde C; Barros JC; Chiattone R; Paz A; Silla L; Vigorito AC; Miranda E; Funke VA; Flowers ME
Eur J Haematol; 2015 Nov; 95(5):421-5. PubMed ID: 25645430
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia.
Schmitz N; Beksac M; Hasenclever D; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley JF; Gorin NC; Szer J; Bradstock K; Buzyn A; Clark P; Borkett K; Gratwohl A;
Blood; 2002 Aug; 100(3):761-7. PubMed ID: 12130483
[TBL] [Abstract][Full Text] [Related]
17. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
[TBL] [Abstract][Full Text] [Related]
18. Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.
Alousi A; Wang T; Hemmer MT; Spellman SR; Arora M; Couriel DR; Pidala J; Anderlini P; Boyiadzis M; Bredeson CN; Cahn JY; Cairo MS; Gadalla SM; Hashmi SK; Gale RP; Kanda J; Kamble RT; Kharfan-Dabaja MA; Litzow MR; Ringden O; Saad AA; Schultz KR; Verdonck LF; Waller EK; Yared JA; Holtan SG; Weisdorf DJ
Biol Blood Marrow Transplant; 2019 Feb; 25(2):270-278. PubMed ID: 30292009
[TBL] [Abstract][Full Text] [Related]
19. Graft monocytic myeloid-derived suppressor cell content predicts the risk of acute graft-versus-host disease after allogeneic transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells.
Vendramin A; Gimondi S; Bermema A; Longoni P; Rizzitano S; Corradini P; Carniti C
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2049-55. PubMed ID: 25246295
[TBL] [Abstract][Full Text] [Related]
20. Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.
Chu R; Brazauskas R; Kan F; Bashey A; Bredeson C; Camitta B; Chiang KY; Frangoul H; Gale RP; Gee A; George B; Goldman FD; Gross TG; Gupta V; Hale GA; Isola L; Ispizua AU; Lazarus H; Marsh J; Russell J; Sabloff M; Waller EK; Eapen M
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1018-24. PubMed ID: 21034842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
